➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Mallinckrodt
Moodys
Colorcon
Harvard Business School

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

Bracco Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Bracco
International Patents:15
US Patents:3
Tradenames:64
Ingredients:32
NDAs:40

Drugs and US Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco RENOGRAFIN-76 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010040-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Get Started for $10   Get Started for $10
Bracco ISOVUE-250 iopamidol INJECTABLE;INJECTION 020327-002 Oct 12, 1994 RX Yes Yes   Get Started for $10   Get Started for $10
Bracco RENO-DIP diatrizoate meglumine INJECTABLE;INJECTION 010040-012 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10
Bracco ORAGRAFIN SODIUM ipodate sodium CAPSULE;ORAL 012967-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10
Bracco MINITEC technetium tc-99m sodium pertechnetate generator SOLUTION;INJECTION, ORAL 017339-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10
Bracco ISOVUE-M 200 iopamidol INJECTABLE;INJECTION 018735-001 Dec 31, 1985 RX Yes Yes   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489-001 Oct 9, 2003 4,885,363   Get Started for $10
Bracco CARDIOTEC technetium tc-99m teboroxime kit INJECTABLE;INJECTION 019928-001 Dec 19, 1990 6,056,941   Get Started for $10
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-004 Nov 23, 2004 4,916,246   Get Started for $10
Bracco PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489-001 Oct 9, 2003 5,474,756   Get Started for $10
Bracco PROHANCE gadoteridol INJECTABLE;INJECTION 020131-001 Nov 16, 1992 4,885,363   Get Started for $10
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 5,686,060   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for Bracco Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2822954 18C1035 France   Get Started for $10 PRODUCT NAME: BICTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER BICTEGRAVIR DE SODIUM; REGISTRATION NO/DATE: EU/1/18/1289 20180625
1912999 2014/058 Ireland   Get Started for $10 PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REGISTRATION NO/DATE: EU/1/14/924/001-002 20140516
2822954 LUC00083 Luxembourg   Get Started for $10 PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; AUTHORISATION NUMBER AND DATE: EU/1/18/1289 20180625
1713823 1490064-1 Sweden   Get Started for $10 PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
1556389 2015/074 Ireland   Get Started for $10 PRODUCT NAME: CEFTOLOZANE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR A SULFURIC ACID SALT; REGISTRATION NO/DATE: EU/1/15/1032/001 20150918
1556389 16C0004 France   Get Started for $10 PRODUCT NAME: CEFTOLOZANE,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,PLUS PARTICULIEREMENT UN SEL D'ACIDE SULFURIQUE; REGISTRATION NO/DATE: EU/1/15/1032 20150922
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Express Scripts
Merck
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.